Thrivent Financial for Lutherans’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.77M Sell
16,026
-1,390
-8% -$258K 0.01% 1214
2025
Q4
$3.47M Buy
17,416
+2,650
+18% +$481K 0.01% 1108
2025
Q3
$2.31M Sell
14,766
-7,410
-33% -$1.18M ﹤0.01% 1245
2025
Q2
$3.37M Buy
22,176
+20,172
+1,007% +$2.69M 0.01% 1020
2025
Q1
$302K Sell
2,004
-3,419
-63% -$573K ﹤0.01% 2230
2024
Q4
$1M Sell
5,423
-327,239
-98% -$63M ﹤0.01% 1903
2024
Q3
$65.5M Sell
332,662
-41,997
-11% -$8.73M 0.12% 230
2024
Q2
$77.4M Sell
374,659
-191,205
-34% -$43.3M 0.16% 172
2024
Q1
$153M Buy
565,864
+123,065
+28% +$29.4M 0.31% 67
2023
Q4
$105M Buy
442,799
+408,643
+1,196% +$80.4M 0.23% 113
2023
Q3
$6.69M Sell
34,156
-8
-0% -$1.64K 0.02% 714
2023
Q2
$7.18M Buy
34,164
+31,980
+1,464% +$6.36M 0.02% 729
2023
Q1
$441K Sell
2,184
-21,095
-91% -$4.78M ﹤0.01% 2177
2022
Q4
$5.07M Sell
23,279
-60,288
-72% -$13.2M 0.01% 799
2022
Q3
$16.4M Buy
83,567
+22,411
+37% +$4.84M 0.05% 444
2022
Q2
$13.1M Buy
61,156
+11,318
+23% +$2.77M 0.03% 523
2022
Q1
$14.2M Sell
49,838
-38,917
-44% -$12M 0.03% 577
2021
Q4
$33.4M Buy
88,755
+36,769
+71% +$14.3M 0.06% 331
2021
Q3
$21.5M Buy
51,986
+194
+0.4% +$80.6K 0.04% 442
2021
Q2
$19.2M Sell
51,792
-10,907
-17% -$3.64M 0.04% 476
2021
Q1
$18.2M Sell
62,699
-3,482
-5% -$968K 0.04% 475
2020
Q4
$16.5M Sell
66,181
-111
-0.2% -$26.4K 0.04% 500
2020
Q3
$15M Sell
66,292
-4,400
-6% -$913K 0.04% 487
2020
Q2
$12.3M Sell
70,692
-16,697
-19% -$2.66M 0.04% 501
2020
Q1
$11M Sell
87,389
-79,413
-48% -$11.9M 0.04% 479
2019
Q4
$25.5M Buy
166,802
+76,880
+85% +$10.6M 0.07% 318
2019
Q3
$11.9M Sell
89,922
-3,598
-4% -$482K 0.04% 457
2019
Q2
$13.3M Buy
93,520
+440
+0.5% +$59.7K 0.04% 443
2019
Q1
$13.5M Buy
93,080
+264
+0.3% +$34.7K 0.04% 403
2018
Q4
$10.5M Buy
92,816
+649
+0.7% +$81.3K 0.04% 436
2018
Q3
$12.4M Buy
92,167
+81,250
+744% +$10M 0.04% 437
2018
Q2
$1.23M Sell
10,917
-173
-2% -$18.7K ﹤0.01% 1135
2018
Q1
$1.18M Buy
11,090
+755
+7% +$81.4K ﹤0.01% 1138
2017
Q4
$1.13M Buy
10,335
+175
+2% +$19K ﹤0.01% 1181
2017
Q3
$1.1M Sell
10,160
-86,520
-89% -$8.89M ﹤0.01% 1121
2017
Q2
$9.78M Sell
96,680
-52,170
-35% -$4.8M 0.04% 405
2017
Q1
$13.4M Buy
148,850
+25,020
+20% +$2.13M 0.06% 315
2016
Q4
$9.44M Buy
123,830
+108,330
+699% +$8.23M 0.04% 412
2016
Q3
$1.29M Buy
15,500
+8,760
+130% +$734K 0.01% 1025
2016
Q2
$556K Buy
6,740
+880
+15% +$72.5K ﹤0.01% 1371
2016
Q1
$445K Buy
5,860
+480
+9% +$35.5K ﹤0.01% 1419
2015
Q4
$432K Buy
5,380
+130
+2% +$9.38K ﹤0.01% 1417
2015
Q3
$333K Buy
5,250
+500
+11% +$35.9K ﹤0.01% 1397
2015
Q2
$334K Sell
4,750
-31,080
-87% -$2.3M ﹤0.01% 1341
2015
Q1
$2.84M Buy
35,830
+80
+0.2% +$5.9K 0.02% 610
2014
Q4
$2.27M Sell
35,750
-2,400
-6% -$150K 0.01% 659
2014
Q3
$2.28M Hold
38,150
0.01% 648
2014
Q2
$2.04M Buy
38,150
+800
+2% +$43.9K 0.01% 699
2014
Q1
$2.25M Buy
37,350
+1,450
+4% +$84.5K 0.01% 571
2013
Q4
$1.9M Sell
35,900
-6,400
-15% -$321K 0.01% 617
2013
Q3
$1.96M Buy
+42,300
New +$1.94M 0.01% 588

Other funds holding CRL